Navigation Links
Donation for new Center for Pharmaceutical Nanotechnology and Nanotoxicology
Date:12/18/2008

Prof. Moein Moghimi (Professor of Biopharmacy and Nanomedicine, Department of Pharmaceutics and Analytical chemistry) and colleagues have received 28 million DKK (approximately 3.75 million Euros) from the Danish Council for Strategic Research (DSF) to set The Centre for Pharmaceutical Nanotechnology and Nanotoxicology (CPNN) at the Faculty of Pharmaceutical Sciences starting April 2009.

Prof. Moghimi will act as the Director of the Centre and Prof. Thomas Bjrnholm (Head of the NanoScience Centre) will be the Chairman of the Steering Committee.

The development of a wide spectrum of promising nanoscale materials, either in their own right or as a component of multifunctional platforms, is beginning to have a paradigm-shifting impact in medicine; they are changing the foundations of disease diagnosis, monitoring and treatment, and turning molecular discoveries into benefits for patients. Research into delivery and targeting of pharmaceutical, therapeutic, and diagnostic agents via intravenous and interstitial routes of administration with particulate drug carriers and nanoconstructs is at the forefront of projects in nanomedicine, but the biological performance of such delivery systems still requires optimization.

The principal investigator Prof. Moghimi said "the future of particulate and polymeric nanomedicines will depend on rational design of nanotechnology materials and tools based around a detailed and thorough molecular understanding of biological processes, rather than forcing applications for some materials currently in vogue". Therefore, the prime research focus of the Centre is to unravel the molecular basis of nanomaterial performance and toxicity through "structure-activity" assessments at membrane organelle, cellular and animal level in combination with and by improving/optimizing the performance of the state-of-the-art bio-nanotechnology techniques. This integrated and multidisciplinary approach is expected to improve therapeutic benefit-to-risk ratio.

CPNN also intend to provide "bench-mark protocols" for toxicity evaluation of nanomedicines in animals, and at cellular and molecular levels, as the sensitivity and precision of the standard toxicological procedures are of arguable value in nanomedicine research and development as it is limited to spotting extreme toxicity.

CPNN also receives substantial in-kind contribution (at present in the region of 10 million DKK) from pharmaceutical and biotechnology industry. The Centre has a critical mass of academic and industrial expertise and necessary tools to conduct the task, thus reinforcing competitiveness at international level. Partners include NanoScience Centre at the University of Copenhagen (Prof. Bjrnholm and Associate Prof. D. Stamou), Faculty of Health Sciences at University of Copenhagen (Prof. S. Loft), DTU-Nanotech (Senior Scientist T. Andresen), Lundbeck A/S, LiPlasome A/S and Nordic Vaccine A/S. The international dimension of CPNN is further reflected through collaborations with centres of excellence world-wide including USA, Switzerland, EU as well as the growth countries China and Hungary.

Prof. Moghimi also said "our success would help the transformation of National and European biotechnology and pharmaceutical industries towards a knowledge-intensive, globally competitive one. In addition, the safe use of nanoparticulate delivery systems will also give Denmark and EU significant savings in pharmaceutical spending, which continue to grow".

Training of at least 9 PhD students and 5-6 post doctoral scientists are envisaged at the highest level gaining maximum benefit through close collaboration with industrial partners and international network as well as by the training offered through the Graduate Schools of Drug Discovery (Faculty of Pharmaceutical Sciences) and Nanotechnology (Nano-Science Center).


'/>"/>

Contact: Professor Seyed Moein Moghimi
momo@farma.ku.dk
453-533-6528
University of Copenhagen
Source:Eurekalert

Related biology news :

1. Trustee makes donation to start new solar energy research center at Rensselaer
2. Georgia Tech/Emory Center to study origin of life
3. Woods Hole Research Center to lead undergraduate initiative in the Siberian Arctic
4. $10 million gift to support cutting-edge epigenome center at USC
5. 3 Columbia University Medical Center faculty elected to Institute of Medicine
6. NHGRI funds new Centers for Excellence in Ethical, Legal and Social Implications Research
7. NYUs Center for Genomics & Systems Biology receives $4.4 million NSF grant
8. Monsanto expands sponsorship for Peking-Yale Joint Agrobiotechnology Center
9. Woods Hole Research Center debuts new image mosaic that will strengthen global forest monitoring
10. DFG to establish 10 new collaborative research centers
11. Ireland Cancer Center researchers advance stem cell gene therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2016)... Securus Technologies, a leading provider of civil ... corrections and monitoring, announced today that it has offered ... an independent technology judge determine who has the largest ... telephone calling platform, and the best customer service. ... of what we do – which clearly is not ...
(Date:11/17/2016)... 2016  AIC announces that it has just released a new white paper authored ... scale-out plus high speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
Breaking Biology News(10 mins):
(Date:12/6/2016)... Laurel, NJ (PRWEB) , ... December 06, 2016 ... ... white paper on December 1, 2016 asking the Federal Drug Administration (FDA) to ... the study of OA, OARSI is concerned about the growing population of OA ...
(Date:12/6/2016)... Colorado (PRWEB) , ... December 06, 2016 , ... ... dynamic aqueous plasma technology platforms, announced today that the company has engaged in ... Research and Development Agreement (MRDA) with the CSU Office of the Vice President ...
(Date:12/6/2016)... PHOENIX and SAN DIEGO ... (OTCQB:CELZ) announced the appointment of Santosh Kesari , ... Board. Dr. Kesari will leverage his experience in neurology and ... its adult stem cell for treatment of stroke. The AmnioStem ... amniotic fluid, which has previously shown therapeutic activity in ...
(Date:12/6/2016)... MELBOURNE, Australia , Dec. 6, 2016  The ... Health Informatics Society of Australia (HISA) today announced ... technology startup exchange program between Australia ... city in the world. HISA and ... are initiating a program to create a global health ...
Breaking Biology Technology: